B1R mRNA expression in (A) HUVECs (n=6) or (B) HAECs (n=6) subjected to varying LSS (0-10 dyn/cm2, 12h), then stimulated or not with IL-1β (10ng/mL, 4h) prior or not to treatment with (C) the NFκB inhibitor (BAY 11-7082, 20μM, n=6). (D) Following LSS HUVECs were treated with native LDL (nLDL, 20μg/ml) or oxidized LDL (oxLDL, 20μg/ml, 3h, n=3). * P<0.01, ** P<0.05, nd: non-determined, ns: non-significant.